Sfoglia per AUTORE
MORAITIS AG
Collezione AOU San Luigi di Orbassano
Items : 3
Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study. in Frontiers in endocrinology / Front Endocrinol (Lausanne). 2022 Apr 27;13:899616. doi: 10.3389/fendo.2022.899616. eCollection 2022
2022
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Pivonello R; Bancos I; Feelders RA; Kargi AY; Kerr JM; Gordon MB; Mariash CN; Terzolo M; Ellison N; Moraitis AG;
Glucocorticoid Receptor Antagonism Upregulates Somatostatin Receptor Subtype 2 Expression in ACTH-Producing Neuroendocrine Tumors: New Insight Based on the Selective Glucocorticoid Receptor Modulator Relacorilant. in Frontiers in endocrinology / Front Endocrinol (Lausanne). 2022 Jan 4;12:793262. doi: 10.3389/fendo.2021.793262. eCollection 2021.
2021
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Pivonello R; Munster PN; Terzolo M; Ferrigno R; Simeoli C; Puglisi S; Bali U; Moraitis AG; Pivonello R; Munster PN; Terzolo M; Ferrigno R; Simeoli C; Puglisi S; Bali U; Moraitis AG;
Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study. in Frontiers in endocrinology / Front Endocrinol (Lausanne). 2021 Jul 14;12:662865. doi: 10.3389/fendo.2021.662865. eCollection 2021
2021
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Pivonello R; Bancos I; Feelders RA; Kargi AY; Kerr JM; Gordon MB; Mariash CN; Terzolo M; Ellison N; Moraitis AG;